Overview
Acute kidney injury (AKI) remains a serious and costly complication following PCI and PVI procedures. This one‑hour webinar highlights contemporary data and best practices for AKI risk assessment and prevention, with a focus on clinical evidence supporting the use of iso‑osmolar iodinated contrast agents. Through a real‑world patient case and an expert panel discussion, faculty will translate trial data and practical experience into actionable strategies for contrast selection, procedural planning, and post‑procedural management to help optimize renal and cardiovascular outcomes.
Learning Objectives
At the end of this activity, participants should be able to:
- Review current clinical data supporting the use of iso‑osmolar iodinated contrast agents for reducing the risk of AKI in patients undergoing PCI and peripheral vascular interventional (PVI) procedures
- Apply evidence‑based strategies for AKI risk assessment, contrast selection, and procedural planning using real‑world PCI and PVI case scenarios
- Integrate expert panel insights into post‑procedural management and practice decisions aimed at optimizing renal and cardiovascular outcomes
Agenda
- Moderator: Dr. Banerjee
- Preventing AKI Before and During PCI/PVI, Dr. Seto
- A Case of Optimized Contrast Use, Dr. Sundaram
- Post PCI and PVI Management for Reduced AKI Risk, Dr. Altin
- Iso-Osmolar Iodinated Contrast Agent: Data and Practice, Dr. Mixon
Subhash Banerjee, MD, FSCAI
S. Elissa Altin, MD, FSCAI
Arnold H. Seto, MD, MPA, FSCAI
Registration
Cost: Free
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from GE Healthcare.
Accredited Continuing Education Information
Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful Completion
Participate in the live activity and complete the evaluation to obtain credit.
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
Planning Process
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.
All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.
Faculty will not actively promote or sell products or services that serve their personal professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.
Events Schedule
Learning opportunities from SCAI for the interventional cardiology team.